Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis

OBJECTIVE: The objective was to determine if dose reduction is non-inferior to full-dose TNFi to maintain low disease activity (LDA) in patients already in remission with TNFi, in axial spondyloarthritis. METHODS: Randomized, parallel, non-inferiority, open-label multicentre clinical trial. Patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arthritis Res Ther
Asıl Yazarlar: Gratacós, Jordi, Pontes, Caridad, Juanola, Xavier, Sanz, Jesús, Torres, Ferran, Avendaño, Cristina, Vallano, Antoni, Calvo, Gonzalo, de Miguel, Eugenio, Sanmartí, Raimon
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6323809/
https://ncbi.nlm.nih.gov/pubmed/30621746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1772-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller